Management and Outcomes of Unilateral Group D Tumors in Retinoblastoma
Saima Amin,1 Mays AlJboor,1 Mario D Toro,2,3 Robert Rejdak,2 Katarzyna Nowomiejska,2 Rashed Nazzal,4 Mona Mohammad,1 Maysa Al-Hussaini,5 Jakub Khzouz,5 Sara Banat,1 Reem AlJabari,1 Imad Jaradat,6 Mustafa Mehyar,1 Iyad Sultan,7 Ibrahim AlNawaiseh,1 Yacoub A Yousef1 1Department of Surgery (Ophthalmolo...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/f4d4a9f90d534338968c32c981cb2d2e |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:f4d4a9f90d534338968c32c981cb2d2e |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:f4d4a9f90d534338968c32c981cb2d2e2021-12-02T15:14:11ZManagement and Outcomes of Unilateral Group D Tumors in Retinoblastoma1177-5483https://doaj.org/article/f4d4a9f90d534338968c32c981cb2d2e2021-01-01T00:00:00Zhttps://www.dovepress.com/management-and-outcomes-of-unilateral-group-d-tumors-in-retinoblastoma-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Saima Amin,1 Mays AlJboor,1 Mario D Toro,2,3 Robert Rejdak,2 Katarzyna Nowomiejska,2 Rashed Nazzal,4 Mona Mohammad,1 Maysa Al-Hussaini,5 Jakub Khzouz,5 Sara Banat,1 Reem AlJabari,1 Imad Jaradat,6 Mustafa Mehyar,1 Iyad Sultan,7 Ibrahim AlNawaiseh,1 Yacoub A Yousef1 1Department of Surgery (Ophthalmology), King Hussein Cancer Centre (KHCC), Amman, Jordan; 2Department of General Ophthalmology and Pediatric Ophthalmology Service, Medical University of Lublin, Lublin, Poland; 3Faculty of Medical Sciences, Collegium Medicum Cardinal Stefan Wyszyński University, Warsaw, Poland; 4Shami Eye Center, Amman, Jordan; 5Department of Pathology, King Hussein Cancer Centre (KHCC), Amman, Jordan; 6Department of Radiation Oncology, King Hussein Cancer Centre (KHCC), Amman, Jordan; 7Department of Pediatric Oncology, King Hussein Cancer Centre (KHCC), Amman, JordanCorrespondence: Yacoub A YousefDepartment of Surgery (Ophthalmology), King Hussein Cancer Centre (KHCC), Queen Rania Al-Abdullah Street P.O Box 1269, Amman 11941, JordanTel +962 787228749Fax +962 5300460/1552Email yyousef@khcc.joMario D ToroDepartment of General Ophthalmology and Pediatric Ophthalmology Service, Medical University of Lublin, Ul. Chmielna 1, Lublin 20079, PolandTel +48 815326149Fax +48 815324827Email toro.mario@email.itPurpose: Retinoblastoma presents most commonly as advanced unilateral disease, particularly in developing countries for which primary enucleation has been the preferred method of treatment. However, with the evolution of newer treatment modalities including intravitreal chemotherapy, intra-arterial chemotherapy and newer chemotherapeutic combinations, a trend towards more conservative approaches is being observed. Our aim is to evaluate outcomes of group D eyes following conservative and non-conservative treatment options.Patients and Methods: The ocular oncology database was used to identify eyes with unilateral retinoblastoma that fulfilled the International Intraocular Retinoblastoma Classification (IIRC) group D criteria from August 2010 to August 2018 and these were retrospectively reviewed. Overall, 39 eyes were identified.Results: Nineteen (49%) eyes underwent primary enucleation and 20 (51%) received eye-conserving treatment. Eye salvage was possible in 15 (75%) eyes in the attempted salvage group. None of the patient revealed signs of metastasis. All eyes received conventional chemotherapy (carboplatin, vincristine, etoposide) and focal laser therapy. Additional treatment modalities offered included intravitreal chemotherapy, intra-arterial chemotherapy and topotecan. Three (11%) eyes in the primary enucleation group showed high-risk features on histopathology and none developed metastasis.Conclusion: The results of the study seem promising and conservative measures can be adopted in selected unilateral group D eyes.Keywords: ocular oncology, chemotherapy, enucleation, eye-conserving treatmentAmin SAlJboor MToro MDRejdak RNowomiejska KNazzal RMohammad MAl-Hussaini MKhzouz JBanat SAlJabari RJaradat IMehyar MSultan IAlNawaiseh IYousef YADove Medical Pressarticleocular oncologychemotherapyenucleationeye-conserving treatmentOphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 15, Pp 65-72 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
ocular oncology chemotherapy enucleation eye-conserving treatment Ophthalmology RE1-994 |
| spellingShingle |
ocular oncology chemotherapy enucleation eye-conserving treatment Ophthalmology RE1-994 Amin S AlJboor M Toro MD Rejdak R Nowomiejska K Nazzal R Mohammad M Al-Hussaini M Khzouz J Banat S AlJabari R Jaradat I Mehyar M Sultan I AlNawaiseh I Yousef YA Management and Outcomes of Unilateral Group D Tumors in Retinoblastoma |
| description |
Saima Amin,1 Mays AlJboor,1 Mario D Toro,2,3 Robert Rejdak,2 Katarzyna Nowomiejska,2 Rashed Nazzal,4 Mona Mohammad,1 Maysa Al-Hussaini,5 Jakub Khzouz,5 Sara Banat,1 Reem AlJabari,1 Imad Jaradat,6 Mustafa Mehyar,1 Iyad Sultan,7 Ibrahim AlNawaiseh,1 Yacoub A Yousef1 1Department of Surgery (Ophthalmology), King Hussein Cancer Centre (KHCC), Amman, Jordan; 2Department of General Ophthalmology and Pediatric Ophthalmology Service, Medical University of Lublin, Lublin, Poland; 3Faculty of Medical Sciences, Collegium Medicum Cardinal Stefan Wyszyński University, Warsaw, Poland; 4Shami Eye Center, Amman, Jordan; 5Department of Pathology, King Hussein Cancer Centre (KHCC), Amman, Jordan; 6Department of Radiation Oncology, King Hussein Cancer Centre (KHCC), Amman, Jordan; 7Department of Pediatric Oncology, King Hussein Cancer Centre (KHCC), Amman, JordanCorrespondence: Yacoub A YousefDepartment of Surgery (Ophthalmology), King Hussein Cancer Centre (KHCC), Queen Rania Al-Abdullah Street P.O Box 1269, Amman 11941, JordanTel +962 787228749Fax +962 5300460/1552Email yyousef@khcc.joMario D ToroDepartment of General Ophthalmology and Pediatric Ophthalmology Service, Medical University of Lublin, Ul. Chmielna 1, Lublin 20079, PolandTel +48 815326149Fax +48 815324827Email toro.mario@email.itPurpose: Retinoblastoma presents most commonly as advanced unilateral disease, particularly in developing countries for which primary enucleation has been the preferred method of treatment. However, with the evolution of newer treatment modalities including intravitreal chemotherapy, intra-arterial chemotherapy and newer chemotherapeutic combinations, a trend towards more conservative approaches is being observed. Our aim is to evaluate outcomes of group D eyes following conservative and non-conservative treatment options.Patients and Methods: The ocular oncology database was used to identify eyes with unilateral retinoblastoma that fulfilled the International Intraocular Retinoblastoma Classification (IIRC) group D criteria from August 2010 to August 2018 and these were retrospectively reviewed. Overall, 39 eyes were identified.Results: Nineteen (49%) eyes underwent primary enucleation and 20 (51%) received eye-conserving treatment. Eye salvage was possible in 15 (75%) eyes in the attempted salvage group. None of the patient revealed signs of metastasis. All eyes received conventional chemotherapy (carboplatin, vincristine, etoposide) and focal laser therapy. Additional treatment modalities offered included intravitreal chemotherapy, intra-arterial chemotherapy and topotecan. Three (11%) eyes in the primary enucleation group showed high-risk features on histopathology and none developed metastasis.Conclusion: The results of the study seem promising and conservative measures can be adopted in selected unilateral group D eyes.Keywords: ocular oncology, chemotherapy, enucleation, eye-conserving treatment |
| format |
article |
| author |
Amin S AlJboor M Toro MD Rejdak R Nowomiejska K Nazzal R Mohammad M Al-Hussaini M Khzouz J Banat S AlJabari R Jaradat I Mehyar M Sultan I AlNawaiseh I Yousef YA |
| author_facet |
Amin S AlJboor M Toro MD Rejdak R Nowomiejska K Nazzal R Mohammad M Al-Hussaini M Khzouz J Banat S AlJabari R Jaradat I Mehyar M Sultan I AlNawaiseh I Yousef YA |
| author_sort |
Amin S |
| title |
Management and Outcomes of Unilateral Group D Tumors in Retinoblastoma |
| title_short |
Management and Outcomes of Unilateral Group D Tumors in Retinoblastoma |
| title_full |
Management and Outcomes of Unilateral Group D Tumors in Retinoblastoma |
| title_fullStr |
Management and Outcomes of Unilateral Group D Tumors in Retinoblastoma |
| title_full_unstemmed |
Management and Outcomes of Unilateral Group D Tumors in Retinoblastoma |
| title_sort |
management and outcomes of unilateral group d tumors in retinoblastoma |
| publisher |
Dove Medical Press |
| publishDate |
2021 |
| url |
https://doaj.org/article/f4d4a9f90d534338968c32c981cb2d2e |
| work_keys_str_mv |
AT amins managementandoutcomesofunilateralgroupdtumorsinretinoblastoma AT aljboorm managementandoutcomesofunilateralgroupdtumorsinretinoblastoma AT toromd managementandoutcomesofunilateralgroupdtumorsinretinoblastoma AT rejdakr managementandoutcomesofunilateralgroupdtumorsinretinoblastoma AT nowomiejskak managementandoutcomesofunilateralgroupdtumorsinretinoblastoma AT nazzalr managementandoutcomesofunilateralgroupdtumorsinretinoblastoma AT mohammadm managementandoutcomesofunilateralgroupdtumorsinretinoblastoma AT alhussainim managementandoutcomesofunilateralgroupdtumorsinretinoblastoma AT khzouzj managementandoutcomesofunilateralgroupdtumorsinretinoblastoma AT banats managementandoutcomesofunilateralgroupdtumorsinretinoblastoma AT aljabarir managementandoutcomesofunilateralgroupdtumorsinretinoblastoma AT jaradati managementandoutcomesofunilateralgroupdtumorsinretinoblastoma AT mehyarm managementandoutcomesofunilateralgroupdtumorsinretinoblastoma AT sultani managementandoutcomesofunilateralgroupdtumorsinretinoblastoma AT alnawaisehi managementandoutcomesofunilateralgroupdtumorsinretinoblastoma AT yousefya managementandoutcomesofunilateralgroupdtumorsinretinoblastoma |
| _version_ |
1718387606727688192 |